Incidence, mortality, and cost trends in nonventilator hospital-acquired pneumonia in medicaid beneficiaries, 2015-2019

Karen K. Giuliano, Dian Baker, Madhuli Thakkar-Samtani, Michael Glick, Marcos I. Restrepo, Frank A. Scannapieco, Lisa J. Heaton, Julie Frantsve-Hawley

Producción científica: Articlerevisión exhaustiva

3 Citas (Scopus)

Resumen

Nonventilator hospital-acquired pneumonia is associated with substantial morbidity, mortality, and costs during an episode of acute care. We examined NVHAP incidence, mortality, and costs of Medicaid beneficiaries over a 5-year period (2015-2019). Overall NVHAP incidence was 2.63 per 1,000 patient days, and mortality was 7.76%, with an excess cost per NVHAP case of $20,189.

Idioma originalEnglish (US)
Páginas (desde-hasta)227-230
Número de páginas4
PublicaciónAmerican Journal of Infection Control
Volumen51
N.º2
DOI
EstadoPublished - feb 2023
Publicado de forma externa

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases
  • Health Policy
  • Epidemiology

Huella

Profundice en los temas de investigación de 'Incidence, mortality, and cost trends in nonventilator hospital-acquired pneumonia in medicaid beneficiaries, 2015-2019'. En conjunto forman una huella única.

Citar esto